rxstat › Shortages › Tenofovir Disoproxil
Tenofovir Disoproxil shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Tenofovir Disoproxil products are in shortage in Canada (2 of 6 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
In shortage since
May 5, 2025
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageTENOFOVIR
300MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02523922 · since Jul 2, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortageMYLAN-TENOFOVIR DISOPROXIL
300MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02452634 · since May 5, 2025, no end estimate · Disruption of the manufacture of the drug.
DiscontinuedTEVA-TENOFOVIR
300MG · TABLET · TEVA CANADA LIMITED
DIN 02403889
ResolvedAURO-TENOFOVIR
300MG · TABLET · AURO PHARMA INC
DIN 02460173 · ended Nov 13, 2024 · Demand increase for the drug.
ResolvedPMS-TENOFOVIR
300MG · TABLET · PHARMASCIENCE INC
DIN 02453940 · ended Sep 29, 2024 · Disruption of the manufacture of the drug.
ResolvedAURO-TENOFOVIR
300MG · TABLET · AURO PHARMA INC
DIN 02460173 · ended Nov 10, 2023 · Demand increase for the drug.
AvoidedMYLAN-TENOFOVIR DISOPROXIL
300MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02452634 · ended Feb 6, 2023 · Shortage of an active ingredient.
ResolvedTEVA-TENOFOVIR
300MG · TABLET · TEVA CANADA LIMITED
DIN 02403889 · ended Dec 14, 2022 · Disruption of the manufacture of the drug.
ResolvedAURO-TENOFOVIR
300MG · TABLET · AURO PHARMA INC
DIN 02460173 · ended Jan 19, 2021 · Demand increase for the drug.
ResolvedTEVA-TENOFOVIR
300MG · TABLET · TEVA CANADA LIMITED
DIN 02403889 · ended Dec 16, 2020 · Disruption of the manufacture of the drug.
ResolvedAURO-TENOFOVIR
300MG · TABLET · AURO PHARMA INC
DIN 02460173 · ended Oct 30, 2020 · Demand increase for the drug.
ResolvedAPO-TENOFOVIR
300MG · TABLET · APOTEX INC
DIN 02451980 · ended Nov 13, 2020 · Disruption of the manufacture of the drug.
Showing 12 of 17 reports. All reports are on file with Health Canada.
What's happening
Tenofovir Disoproxil is currently affected by 2 active shortage reports filed with Health Canada by SIVEM PHARMACEUTICALS ULC, MYLAN PHARMACEUTICALS ULC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Tenofovir Disoproxil is classified under “DIRECT ACTING ANTIVIRALS” (ATC J05AF).
Recent changes
Common questions
When will Tenofovir Disoproxil be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Tenofovir Disoproxil in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.